10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
Traditional companies are responding to the challenge of digital disruption by partnering with techn...
Read More >
On March 31, 2020, the six Bay Area counties that previously issued the nation’s first Covid-19 she...
Read More >
Seyfarth Synopsis: While paying employees in California is often a challenge, the regular rate of pa...
Read More >
On Monday, August 12, 2019, New York Governor Andrew Cuomo signed off on a major expansion of the st...
Read More >
In our ever-increasing multi-multinational workforce that seems to rely more heavily on foreign labo...
Read More >
Can an employer ever win a motion for summary judgment on a discrimination case in state court? The...
Read More >